期刊文献+

Trend in the incidence and geographic variations of acute lymphoblastic leukemia in Shanghai, China from 2002 to 2006 被引量:4

Trend in the incidence and geographic variations of acute lymphoblastic leukemia in Shanghai, China from 2002 to 2006
原文传递
导出
摘要 Background Great advances have been made in the diagnosis, molecular pathogenesis and treatment of acute lymphoblastic leukemia (ALL) in the past decade. Due to the lack of large population-based studies, the recent trends in the incidence and geographic variations of ALL in Shanghai, China have not been well documented. To better understand the incidence and epidemiological features of ALL in Shanghai, we conducted a retrospective survey based on the database from the Shanghai Center for Disease Control and Prevention (CDC) and the medical records in all large-scale hospitals in Shanghai, especially those 30 major hospitals with hematology department. Methods According to the data from Shanghai CDC, 544 patients, with a median age of 32 years (ranging 1.2-89 years), were diagnosed as de novo ALL from January 1, 2002 to December 31, 2006, and they were followed up until December 31,2007. Results The average annual incidence of ALL in Shanghai was 0.81/100 000. The incidence in men (0.86/100 000) was slightly higher than that in women (0.75/100 000). The age-stratified incidence showed that the incidence was 2.31/100 000 in patients 〈17 years old, 0.54/100 000 in those 18-34 years old, 0.46/100 000 in those 35-59 years old, and 0.94/100 000 in those 〉60 years old. Moreover, there were substantial geographic variations in the incidence of ALL, with the incidence in Chongming county, an island in the east of Shanghai city being 0.60/100 000, much lower than those of other districts. Both French-American-British (FAB) and World Health Organization (WHO) classification systems were applied in the present study. Eighty-eight patients were diagnosed as L1 (26.2%), 193 L2 (57.4%), and 55 L3 (16.4%). For 302 patients with immunophenotypic results, 242 were identified as B cell origin (80.1%), 59 as T cell origin (19.5%), and 1 as biphenotype (0.4%). The leukemia cells in 61 patients co-expressed one or two myeloid antigen (20.2%). For 269 patients with cytogenetic results, the incidences of t(9;22) in patients aged 〈10, 11-17, 18-44, 45-59 and 〉60 years old were 4.2%, 11.4%, 19.2%, 23.1% and 5.3%, respectively. Conclusion Compared with the previous data, the incidence of ALL is increased in Shanghai, and has a geographic distribution characteristic. Background Great advances have been made in the diagnosis, molecular pathogenesis and treatment of acute lymphoblastic leukemia (ALL) in the past decade. Due to the lack of large population-based studies, the recent trends in the incidence and geographic variations of ALL in Shanghai, China have not been well documented. To better understand the incidence and epidemiological features of ALL in Shanghai, we conducted a retrospective survey based on the database from the Shanghai Center for Disease Control and Prevention (CDC) and the medical records in all large-scale hospitals in Shanghai, especially those 30 major hospitals with hematology department. Methods According to the data from Shanghai CDC, 544 patients, with a median age of 32 years (ranging 1.2-89 years), were diagnosed as de novo ALL from January 1, 2002 to December 31, 2006, and they were followed up until December 31,2007. Results The average annual incidence of ALL in Shanghai was 0.81/100 000. The incidence in men (0.86/100 000) was slightly higher than that in women (0.75/100 000). The age-stratified incidence showed that the incidence was 2.31/100 000 in patients 〈17 years old, 0.54/100 000 in those 18-34 years old, 0.46/100 000 in those 35-59 years old, and 0.94/100 000 in those 〉60 years old. Moreover, there were substantial geographic variations in the incidence of ALL, with the incidence in Chongming county, an island in the east of Shanghai city being 0.60/100 000, much lower than those of other districts. Both French-American-British (FAB) and World Health Organization (WHO) classification systems were applied in the present study. Eighty-eight patients were diagnosed as L1 (26.2%), 193 L2 (57.4%), and 55 L3 (16.4%). For 302 patients with immunophenotypic results, 242 were identified as B cell origin (80.1%), 59 as T cell origin (19.5%), and 1 as biphenotype (0.4%). The leukemia cells in 61 patients co-expressed one or two myeloid antigen (20.2%). For 269 patients with cytogenetic results, the incidences of t(9;22) in patients aged 〈10, 11-17, 18-44, 45-59 and 〉60 years old were 4.2%, 11.4%, 19.2%, 23.1% and 5.3%, respectively. Conclusion Compared with the previous data, the incidence of ALL is increased in Shanghai, and has a geographic distribution characteristic.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第16期2406-2410,共5页 中华医学杂志(英文版)
关键词 acute lymphoblastic leukemia EPIDEMIOLOGY INCIDENCE acute lymphoblastic leukemia epidemiology incidence
  • 相关文献

参考文献7

二级参考文献53

  • 1[1]Weir EG, Borowitz MJ. Flow cytometry in the diagnosis of acute leukemia. Semin Hematol, 2001; 38: 124-138
  • 2[2]Huh YO, Ibrahim S. Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease. Hematol Oncol Clin North Am, 2000; 14:1251-1265
  • 3[3]Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood, 1997; 90:2863-2892
  • 4[4]Khalidi HS, Chang KL, Medeiros LJ, et al. Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. Am J Clin Pathol, 1999; 111:467-476
  • 5[5]Hann IM, Richards SM, Eden OB, et al. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party. Leukemia, 1998; 12:1249-1255
  • 6[6]Guglielmi C, Cordone I, Boecklin F, et al. Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications. Leukemia, 1997; 11:1501-1507
  • 7[7]Ciudad J, Orfao A, Vidriales B, et al. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. Haematologica, 1998; 83:1069-1075
  • 8[8]Loken MR, Wells DA. Normal antigen expression in hematopoiesis. Edited by Stewart CC, Nicholson JKA. Immunophenotyping. WILEY-LISS, Inc. 2000: 215-238
  • 9[9]Lucio P, Parreira A, Van-den Beemd MW, et al. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia, 1999; 13:419-427
  • 10[10]McKenna RW, Washington LT, Aquino DB, et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood, 2001; 98:2498-2507

共引文献44

同被引文献17

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部